Abstract
Background: Rheumatoid Arthritis (RA) is a chronic autoimmune disease that results in the systemic inflammation principally affecting the capsule covering the articulating ends of the synovial joints. Pharmacological treatment involving analgesics and anti-inflammatory drugs including steroids suppresses the symptoms and has no effect on disease progression. However, disease modifying anti rheumatic drugs (DMARD) used for the treatment were still analysed for their long-term effects.
Methods: Bromelain has been widely used as phytotherapeutic drug owing to its anti-inflammatory, analgesic, anti-tumor and fibrinolytic properties. Bromelain refers to the combination of thiol proteases available in the extract of Ananas comosus. The fibrinolytic property confers to the reduced pannus development and hence the prevention of disease progression.
Results: It had been inferred that the observed clinical significance may not be solely accounted for its proteolytic property but also may be due to its hormone-like behaviour (i.e.) non-canonical interactions to initiate the signal transduction pathway. The hormone-like behaviour has been studied in cell models, suggesting that bromelain acts at system level. In the present study, molecular behaviour of the wild-type and mutant proteins has been studied by simulating the predicted structure in an aqueous system. The comparative study of the mutants revealed that the mutant with both C26A and H158F mutations has the similar surface properties compared to the other mutants and can be used in studying the non-enzymatic interactions.
Conclusion: Thus, this study may prove to be a tool in experimental studies to understand the hormone-like behaviour and in the construction of oral immunogenic synthetic peptides for treating inflamed conditions.
Keywords: Rheumatoid arthritis, stem bromelain, molecular simulation, hormone-like-behaviour, NSAIDS, catalytic pockets.
Graphical Abstract
Current Pharmaceutical Biotechnology
Title:Comparative Molecular Characterization to Reveal Surface Behaviour of Non-proteolytic Bromelain Mutants
Volume: 19 Issue: 11
Author(s): Soundhara G. Rajan, Ankita Sharma, Pooja Kumari and Sagarika Biswas*
Affiliation:
- Department of Genomics and Molecular Medicine, Institute of Genomics & Integrative Biology, Delhi,India
Keywords: Rheumatoid arthritis, stem bromelain, molecular simulation, hormone-like-behaviour, NSAIDS, catalytic pockets.
Abstract: Background: Rheumatoid Arthritis (RA) is a chronic autoimmune disease that results in the systemic inflammation principally affecting the capsule covering the articulating ends of the synovial joints. Pharmacological treatment involving analgesics and anti-inflammatory drugs including steroids suppresses the symptoms and has no effect on disease progression. However, disease modifying anti rheumatic drugs (DMARD) used for the treatment were still analysed for their long-term effects.
Methods: Bromelain has been widely used as phytotherapeutic drug owing to its anti-inflammatory, analgesic, anti-tumor and fibrinolytic properties. Bromelain refers to the combination of thiol proteases available in the extract of Ananas comosus. The fibrinolytic property confers to the reduced pannus development and hence the prevention of disease progression.
Results: It had been inferred that the observed clinical significance may not be solely accounted for its proteolytic property but also may be due to its hormone-like behaviour (i.e.) non-canonical interactions to initiate the signal transduction pathway. The hormone-like behaviour has been studied in cell models, suggesting that bromelain acts at system level. In the present study, molecular behaviour of the wild-type and mutant proteins has been studied by simulating the predicted structure in an aqueous system. The comparative study of the mutants revealed that the mutant with both C26A and H158F mutations has the similar surface properties compared to the other mutants and can be used in studying the non-enzymatic interactions.
Conclusion: Thus, this study may prove to be a tool in experimental studies to understand the hormone-like behaviour and in the construction of oral immunogenic synthetic peptides for treating inflamed conditions.
Export Options
About this article
Cite this article as:
Rajan G. Soundhara , Sharma Ankita, Kumari Pooja and Biswas Sagarika*, Comparative Molecular Characterization to Reveal Surface Behaviour of Non-proteolytic Bromelain Mutants, Current Pharmaceutical Biotechnology 2018; 19 (11) . https://dx.doi.org/10.2174/1389201019666181017111159
DOI https://dx.doi.org/10.2174/1389201019666181017111159 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Editorial [Hot Topic:The Metabolic Treatment of Coronary Artery Disease and Heart Failure(Executive Editor: Pericle Di Napoli)]
Current Pharmaceutical Design Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued) Echinochrome Pigment Improves Male Rats' Fertility
The Natural Products Journal ATP Synthesis Revisited: New Avenues for the Management of Mitochondrial Diseases
Current Pharmaceutical Design In Vivo, Cardiac-Specific Knockdown of a Target Protein, Malic Enzyme- 1, in Rat via Adenoviral Delivery of DNA for Non-Native miRNA
Current Gene Therapy Homocysteine in Neurology: From Endothelium to Neurodegeneration
Current Nutrition & Food Science Editorial
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology Electrocardiographic and Cardiac Autonomic Indices - Implications of Sex-Specific Risk Stratification in Women After Acute Myocardial Infarction
Current Pharmaceutical Design Life-Threatening Respiratory Syncytial Virus Disease in Children
Current Respiratory Medicine Reviews Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine
Current Pharmaceutical Design Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia
Current Signal Transduction Therapy Effects of Onion Extract on Endogenous Vascular H2S and Adrenomedulin in Rat Atherosclerosis
Current Pharmaceutical Biotechnology Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Current Medicinal Chemistry Targeting TNF-Alpha in HIV-1 Infection
Current Drug Targets Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome
Current Pharmaceutical Design Melanocortins in the Treatment of Male and Female Sexual Dysfunction
Current Topics in Medicinal Chemistry Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis
Current Drug Targets